600796.SHG Zhejiang Qianjiang Biochemical Co Ltd
- Market cap
- CNY 4.18B
- P/E
- 28.4x
- P/B
- 1.16x
- ROE
- 4.8%
- Dividend yield
- 2.35%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600796.SHG undervalued?
Graham number600796.SHG trades 20.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Qianjiang Biochemical Co Ltd fundamental analysis
No fundamental analysis for Zhejiang Qianjiang Biochemical Co Ltd yet.
Zhejiang Qianjiang Biochemical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Qianjiang Biochemical Co Ltd
Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, research, develops, produces, sells, and services biopesticides in China and internationally. The company offers biopesticide products comprising plant growth regulators consisting of gibberellic acid and gibberellic acid A4+A7; insecticides, such as avermectin and emamectin benzoate; and fungicides, including jinggangmycin. It also provides ecological and environmental protection services, including t…
Full company profileZhejiang Qianjiang Biochemical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhejiang Qianjiang Biochemical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 444M | 468M | 443M | 380M | 1.89B | 2.03B | 2.01B | 2.03B | 1.77B | 1.69B | 1.50B |
| Gross Profit | 120M | 95.6M | 65.4M | 34.2M | 408M | 467M | 440M | 479M | 405M | 419M | 414M |
| Operating Income | 26.2M | 56.2M | -33.5M | 32.2M | 174M | 214M | 245M | 231M | 164M | 244M | 259M |
| EBITDA | 99.3M | 102M | 15.2M | 78.5M | 343M | 489M | 579M | 543M | 494M | 449M | 248M |
| Net Income | 32.8M | 41.0M | -44.6M | 19.2M | 96.1M | 148M | 206M | 211M | 160M | 166M | 171M |
| EPS | 0.11 | 0.14 | -0.15 | 0.06 | 0.15 | 0.22 | 0.24 | 0.24 | 0.18 | 0.19 | 0.20 |
| Balance Sheet | |||||||||||
| Total Assets | 1.03B | 1.05B | 947M | 875M | 1.16B | 6.49B | 6.70B | 6.87B | 7.55B | 7.59B | 7.57B |
| Total Liabilities | 394M | 386M | 333M | 241M | 475M | 3.19B | 3.29B | 3.37B | 3.99B | 3.89B | 3.76B |
| Shareholders' Equity | 606M | 632M | 578M | 597M | 1.86B | 2.89B | 3.01B | 3.14B | 3.28B | 3.44B | 3.54B |
| Cash & Short-term Investments | 148M | 160M | 157M | 124M | 531M | 919M | 873M | 876M | 948M | 974M | 846M |
| Total Debt | 163M | 131M | 85.0M | 45.1M | 1.29B | 1.94B | 1.90B | 2.04B | 2.10B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 29.8M | 59.8M | 55.6M | 31.9M | 323M | 369M | 402M | 352M | 373M | 625M | - |
| Capital Expenditure | 37.4M | 33.8M | 50.5M | 21.3M | 103M | 568M | 368M | 234M | 819M | 446M | 131M |
| Free Cash Flow | -7.69M | 25.9M | 5.05M | 10.7M | -21.9M | -200M | 34.4M | 118M | -446M | 179M | -38.8M |
| Ratios | |||||||||||
| ROE | 5.4% | 6.5% | -7.7% | 3.2% | 5.2% | 5.1% | 6.8% | 6.7% | 4.9% | 4.8% | 4.8% |
| ROA | 3.2% | 3.9% | -4.7% | 2.2% | 8.3% | 2.3% | 3.1% | 3.1% | 2.1% | 2.2% | 2.3% |
| Net Profit Margin | 7.4% | 8.8% | -10.1% | 5.0% | 5.1% | 7.3% | 10.3% | 10.4% | 9.0% | 9.8% | 11.4% |
| Debt to Equity | 0.27x | 0.21x | 0.15x | 0.08x | 0.69x | 0.67x | 0.63x | 0.65x | 0.64x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhejiang Qianjiang Biochemical Co Ltd dividends
- Dividend yield
- 2.35%
- Forward dividend
- 0.03 CNY
- Payout ratio
- 59.1%
- Ex-dividend date
- Jul 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 98.3M | 0.11 | 59.1% |
| 2024 | CNY 102M | 0.11 | 63.5% |
| 2023 | CNY 179M | 0.20 | 84.9% |
| 2022 | CNY 194M | 0.23 | 94.1% |
| 2021 | CNY 78.7M | 0.12 | 53.2% |
| 2020 | CNY 69.9M | 0.11 | 72.7% |
| 2019 | CNY 3.36M | 0.01 | 17.5% |
| 2018 | CNY 14.4M | 0.05 | - |
| 2017 | CNY 20.8M | 0.07 | 50.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 11:10 on May 6, 2011.
Who owns Zhejiang Qianjiang Biochemical Co Ltd
- Insiders 76.61%
- Institutions 0.37%
- Public & others 23.03%
- Shares outstanding 867M
- Free float 203M
Zhejiang Qianjiang Biochemical Co Ltd company profile
- Company name
- Zhejiang Qianjiang Biochemical Co Ltd
- Ticker
- 600796.SHG
- ISIN
- CNE000000PG1
- Exchange
- Shanghai Stock Exchange
- Listed since
- Mar 24, 1997
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,809
- Fiscal year end
- December
- Address
- Qianjiang Building, Haining, China, 314400
- Phone
- 86 573 8703 8237
- Website
- 600796.com
About Zhejiang Qianjiang Biochemical Co Ltd
Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, research, develops, produces, sells, and services biopesticides in China and internationally. The company offers biopesticide products comprising plant growth regulators consisting of gibberellic acid and gibberellic acid A4+A7; insecticides, such as avermectin and emamectin benzoate; and fungicides, including jinggangmycin. It also provides ecological and environmental protection services, including the disposal and resource utilization of general solid and medical wastes, sludge, and kitchen waste, as well as sanitation and heat production services. In addition, the company offers water operation services comprising the protection and management of water environment; improvement of lakes and rivers; and investment, development, construction, operation, and management of water supply and drainage infrastructure, sewage treatment infrastructure, and related water projects. Further, it engages in the sale of steam; and construction installation activities. Zhejiang Qianjiang Biochemical Co., Ltd. was founded in 1970 and is headquartered in Haining, China.
Zhejiang Qianjiang Biochemical Co Ltd management
4- Mr. Yuezhong MaFinancial Director & Accounting Supervisor · born 1976
- Mr. Zhanjun ChenDeputy General Manager · born 1984
- Mr. Guoqiang FengDeputy General Manager · born 1972
- Ms. Pingyan LuChief Auditor & Board Secretary · born 1986